We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$877M
AUM Growth
-$34.1M
Cap. Flow
-$15.3M
Cap. Flow %
-1.75%
Top 10 Hldgs %
20.47%
Holding
269
New
8
Increased
55
Reduced
114
Closed
8

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$5.62M
2
TEL icon
TE Connectivity
TEL
+$2.05M
3
V icon
Visa
V
+$1.09M
4
CRM icon
Salesforce
CRM
+$683K
5
WELL icon
Welltower
WELL
+$661K

Top Sells

Rank Stock Value
1
STRP
Straight Path Communications Inc.
STRP
+$5.37M
2
ANSS
Ansys
ANSS
+$3.27M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$1.42M
4
NEOG icon
Neogen
NEOG
+$1.26M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$798K

Sector Composition

Rank Sector Weight
1 Healthcare 16.6%
2 Technology 15.22%
3 Miscellaneous 13.85%
4 Industrials 12.99%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
26
Parker-Hannifin
PH
$116B
$9.42M 1.07%
55,069
+175
+0.3% +$33.1K
IQV icon
27
IQVIA
IQV
$44.4B
$9.09M 1.04%
92,615
+496
+0.5% +$50.1K
DLTR icon
28
Dollar Tree
DLTR
$21.4B
$9.05M 1.03%
95,324
-738
-0.8% -$77.4K
ADP icon
29
Automatic Data Processing
ADP
$110B
$8.98M 1.02%
79,154
-2,195
-3% -$256K
GIS icon
30
General Mills
GIS
$19.5B
$8.89M 1.01%
197,266
-1,685
-0.8% -$91.4K
SYK icon
31
Stryker
SYK
$108B
$8.6M 0.98%
53,455
-553
-1% -$89.1K
GILD icon
32
Gilead Sciences
GILD
$181B
$8.6M 0.98%
114,038
-456
-0.4% -$36.2K
PEP icon
33
PepsiCo
PEP
$185B
$8.51M 0.97%
77,961
+68
+0.1% +$7.73K
VZ icon
34
Verizon
VZ
$214B
$8.46M 0.96%
176,828
+111,817
+172% +$5.62M
MMM icon
35
3M
MMM
$84.7B
$8.31M 0.95%
45,304
+470
+1% +$93.1K
ABBV icon
36
AbbVie
ABBV
$464B
$8.3M 0.95%
87,699
-2,958
-3% -$325K
V icon
37
Visa
V
$700B
$7.75M 0.88%
64,755
+9,009
+16% +$1.09M
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.15T
$7.73M 0.88%
149,780
-880
-0.6% -$48.6K
ROP icon
39
Roper Technologies
ROP
$38.2B
$7.71M 0.88%
27,480
-1,042
-4% -$288K
MKC icon
40
McCormick & Company Non-Voting
MKC
$13.5B
$7.71M 0.88%
144,962
-148
-0.1% -$7.78K
AFL icon
41
Aflac
AFL
$58.8B
$7.71M 0.88%
176,104
– –
NEE icon
42
NextEra Energy
NEE
$170B
$7.32M 0.84%
179,284
-6,920
-4% -$267K
PX
43
DELISTED
Praxair Inc
PX
$7.21M 0.82%
49,955
-589
-1% -$91.6K
CVS icon
44
CVS Health
CVS
$121B
$6.91M 0.79%
111,140
-59
-0.1% -$4.23K
AL
45
DELISTED
Air Lease Corp
AL
$6.66M 0.76%
156,149
+4,500
+3% +$207K
QQQ icon
46
Invesco QQQ Trust
QQQ
$474B
$6.55M 0.75%
40,925
-8,614
-17% -$1.42M
LKQ icon
47
LKQ Corp
LKQ
$6.08B
$6.26M 0.71%
165,032
-2,570
-2% -$104K
ABT icon
48
Abbott
ABT
$177B
$6.25M 0.71%
104,258
-4,187
-4% -$252K
MCD icon
49
McDonald's
MCD
$180B
$6.06M 0.69%
38,775
+18
+0% +$2.96K
SLB icon
50
SLB Ltd
SLB
$80.5B
$6.01M 0.69%
92,789
-8,196
-8% -$572K
1
2
3 4 5

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Family Office held 269 positions worth $877M, down 3.7% from $911M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Family Office's Q1 2018 filing shows 8 new, 55 increased, 114 reduced and 8 closed positions. Its largest new stake was CRISPR Therapeutics: 10,000 shares worth $457K. The largest sale was Straight Path Communications Inc., an estimated $5.37M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Miscellaneous.

  • Boston Family Office's largest Q1 2018 buy was CRISPR Therapeutics: 10,000 shares worth $457K.
  • Boston Family Office added most to Verizon in Q1 2018, an estimated $5.62M increase.
  • Boston Family Office's biggest Q1 2018 reduction was Ansys, cutting an estimated $3.27M.
  • Boston Family Office fully exited Straight Path Communications Inc. in Q1 2018, selling an estimated $5.37M.
  • Boston Family Office's ten largest holdings make up 20% of its $877M portfolio in Q1 2018.
  • Boston Family Office opened 8 new positions and closed 8 in Q1 2018.
  • Boston Family Office's portfolio value fell 3.7% quarter-over-quarter to $877M.

Based on Boston Family Office's 13F filing for Q1 2018, filed 30 Apr 2018.